SCHEMBL5360942

SCHEMBL5360942

CC(C)(C)[Si](C)(C)Oc1ccc([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)c(O[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
CNR2 P34972 1/20 0.40
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
GLA P06280 1/20 0.38
DRD2 P14416 6/20 0.37
ADRA1D P25100 5/20 0.37
ADRA1A P35348 5/20 0.37
ADRA1B P35368 5/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
KDM4E B2RXH2 1/20 0.36
RECQL P46063 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5360944 1.00 POLB (0.40) POLBCNR2ALDH1A1LMNAGAA
SCHEMBL5363070 0.92 ALDH1A1 (0.45) POLBALDH1A1LMNAGAAGLA
SCHEMBL5359450 0.92 ALDH1A1 (0.45) POLBALDH1A1LMNAGAAGLA
SCHEMBL5446985 0.92 POLB (0.42) POLBGAAGLADRD2ADRA1D
SCHEMBL5446988 0.92 POLB (0.42) POLBGAAGLADRD2ADRA1D
SCHEMBL5359455 0.92 ALDH1A1 (0.45) POLBALDH1A1LMNAGAAGLA
SCHEMBL5363835 0.91 HTR1A (0.43) POLBDRD2ADRA1DADRA1AADRA1B
SCHEMBL5362995 0.91 HTR1A (0.41) POLBALDH1A1LMNAGAAGLA
SCHEMBL5363841 0.91 HTR1A (0.43) POLBDRD2ADRA1DADRA1AADRA1B
SCHEMBL5362991 0.91 HTR1A (0.41) POLBALDH1A1LMNAGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7282592-B2 Resorcinol derivatives WARNER-LAMBERT COMPANY (US) 2007-10-16 US disclosed
US-20070122367-A1 RESORCINOL DERIVATIVES PFIZER INC. (US) 2007-05-31 US disclosed
US-7173052-B2 Resorcinol derivatives PFIZER INC. (US) 2007-02-06 US disclosed
US-20050282899-A1 Resorcinol for lightening skin removing color BRADLEY STUART E 2005-12-22 US disclosed
US-6852747-B2 Resorcinol derivatives PFIZER INC. (US) 2005-02-08 US disclosed
US-20030180236-A1 Resorcinol derivatives PFIZER PRODUCTS, INC. 2003-09-25 US disclosed
US-6590105-B2 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits WARNER-LAMBERT COMPANY 2003-07-08 US disclosed
US-20020114770-A1 Resorcinol derivatives PFIZER INC. 2002-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070122367-A1 RESORCINOL DERIVATIVES LRAT, NQO1, ALDH1A2 POLB 2994/4885CNR2 4072/4885ALDH1A1 90/4885
US-20030180236-A1 Resorcinol derivatives LRAT, NQO1, ALDH1A2 POLB 2994/4885CNR2 4072/4885ALDH1A1 90/4885
US-20050282899-A1 Resorcinol for lightening skin removing color RBP4, NQO1, ALDH1A2 POLB 1975/4885CNR2 4308/4885ALDH1A1 164/4885
US-20020114770-A1 Resorcinol derivatives LRAT, NQO1, ALDH1A2 POLB 2994/4885CNR2 4072/4885ALDH1A1 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.